These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7906048)

  • 21. [Epidemiology of the HIV infection].
    Jablonowski H; Jablonowski B
    MMW Fortschr Med; 2009 Apr; 151(18):32-3. PubMed ID: 19769070
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV in women in Delaware.
    Del Med J; 1992 Oct; 64(10):637-9. PubMed ID: 1426426
    [No Abstract]   [Full Text] [Related]  

  • 24. [Discriminative value for AIDS case of erythrocyte sedimentation rate, immunoglobulins IgA and IgM, and beta 2-microglobulin in combination with the CD4+ lymphocyte count].
    Pérez de Oteyza C; Menéndez Martínez MA; Muro García R; Pérez Aznar C; Barberán López J
    An Med Interna; 1998 Aug; 15(8):411-4. PubMed ID: 9780421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV infection in women and children: where are we headed?
    Helfgott AW
    Pediatr AIDS HIV Infect; 1997 Apr; 8(2):86-8. PubMed ID: 11361780
    [No Abstract]   [Full Text] [Related]  

  • 26. Format of regular tables summarising data on reported AIDS cases and HIV-1 antibody positive persons. PHLS AIDS Centre at the Communicable Disease Surveillance Centre and the Communicable Diseases (Scotland) Unit.
    CDR (Lond Engl Rev); 1991 Jan; 1(1):R6-9. PubMed ID: 1669743
    [No Abstract]   [Full Text] [Related]  

  • 27. [Short term projections of infection by the human immunodeficiency (HIV) and the acquired immunodeficiency syndrome (AIDS) in Cameroon].
    Garcia-Calleja JM; Louis JP; Salla R; Trebucq A; Mvondo JL; Zekeng L; Migliani R; Owona R; Kaptue L
    Med Trop (Mars); 1993; 53(2):195-9. PubMed ID: 8412588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
    Müller C; Kukel S; Bauer R
    Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adenosine deaminase (ADA) and beta 2-microglobulin (beta 2M) as discriminating serum markers of progression to AIDS].
    Pérez de Oteyza C; Menéndez Martínez MA; Irazábal C; Enríquez de Salamanca R; Pérez Aznar C; Rebollar JL
    An Med Interna; 1996 May; 13(5):217-21. PubMed ID: 8767867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of adult HIV prevalence as of the end of 1994 in India.
    Anthony B; Mertens TE; Lal S
    Indian J Public Health; 1995; 39(3):79-85. PubMed ID: 8690496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing HIV. Part 8: Controlling an epidemic. 8.6 Epidemiological surveillance for HIV and AIDS.
    Kaldor JM; Crofts N
    Med J Aust; 1996 Sep; 165(5):268-71. PubMed ID: 8816686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T
    An Med Interna; 1999 Sep; 16(9):447-50. PubMed ID: 10609356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic changes in polytransfused hemophiliacs].
    Gamba G
    Haematologica; 1991 Jun; 76 Suppl 3():420-3. PubMed ID: 1752541
    [No Abstract]   [Full Text] [Related]  

  • 34. From the Center for Disease Control and Prevention. Selected data from the HIV/AIDS Surveillance Report through December 1995.
    Pediatr AIDS HIV Infect; 1996 Aug; 7(4):287-304. PubMed ID: 11361723
    [No Abstract]   [Full Text] [Related]  

  • 35. Unlinked anonymous monitoring of HIV prevalence in England and Wales: data to the end of 1993.
    Commun Dis Rep CDR Wkly; 1995 Jan; 5(4):17, 20. PubMed ID: 7533589
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychoneuroimmunologic and behavioral issues in populations at risk for AIDS.
    Schleifer SJ; Keller SE
    Psychiatr Med; 1991; 9(3):395-408. PubMed ID: 1681568
    [No Abstract]   [Full Text] [Related]  

  • 37. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
    Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
    J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand.
    Pattanapanyasat K; Shain H; Noulsri E; Lerdwana S; Thepthai C; Prasertsilpa V; Likanonsakul S; Yothipitak P; Nookhai S; Eksaengsri A
    Cytometry B Clin Cytom; 2005 May; 65(1):29-36. PubMed ID: 15800883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W; Jaruga B; Pawłowska M
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.